Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2705
Selected: 0
NCT IDTitle
NCT04109131A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours
NCT05335031A Study Investigating the Utilization, Effectiveness and Quality of Life in Clinical Practice in Germany for Participants With Relapsing-remitting Multiple Sclerosis Treated With Ozanimod (Zeposia®)
NCT00135382Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen
NCT00978731Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemic Study
NCT00326131A Phase I Study of a Single Dose of Radio-labeled BMS-275183 in Patients With Advanced Cancer
NCT00112580MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery
NCT00160329Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia
NCT06452329A Study to Evaluate Nivolumab in Patients With Unresectable Advanced/Metastatic Gastric Cancer and Gastroesophageal Junction Cancer
NCT02974829REALM China Extension Study
NCT02837029Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer
NCT05413044A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register
NCT03348904Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
NCT03002740Bleeding Events and Oral Anticoagulant Treatment in Non-Valvular Atrial Fibrillation
NCT03611101Companion Protocol for ¹³C-Methacetin Breath Tests in BMS: NCT03486899, NCT03486912 Referenced Trials
NCT00103844Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia
NCT01460160Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
NCT00000660Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma
NCT03950960A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of BMS-986256 in Healthy Participants
NCT06146660A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
NCT02273960Study to Evaluate Safety and Efficacy in Adult Subjects With ITP
NCT02598960An Investigational Immuno-therapy Study of Experimental Medication BMS-986156, Given by Itself or in Combination With Nivolumab in Patients With Solid Cancers or Cancers That Have Spread.
NCT01605994Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-933043 in Healthy Subjects
NCT03044626Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC
NCT01142726Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis
NCT02950766NeoVax Plus Ipilimumab in Renal Cell Carcinoma
NCT02754726Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma
NCT03350126iRECIST Evaluation's Relevance for DCR in MMR/MSI Metastatic Colorectal Cancer Patients on Nivolumab and Ipilimumab
NCT01024062Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC)
NCT06377462Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection
NCT04167462An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea
NCT02546791Frequency and Severity of Pleural Effusion Associated With the Use of Dasatinib in Patients With Chronic Myeloid Leukemia. A Descriptive, Mexican Multicenter Study
NCT03195491A Study of Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Second-Line Nivolumab Monotherapy in Asia
NCT02034565Phase 1 Bioavailability Study of Apixaban Solution Formulation Relative to Apixaban Tablets in Healthy Subjects
NCT02843074Elotuzumab, Lenalidomide and Dexamethasone in Treatment of Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients
NCT00001065A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole
NCT02939365Precision Medicine Offers Belatacept Monotherapy
NCT00339144Study of Dasatinib (BMS-354825) in Patients With Solid Tumors
NCT02456844Study to Investigate the Effect of BMS-986142 on the Pharmacokinetics (PK) of Methotrexate and Probe Substrate Cocktail in Healthy Patients
NCT03788044Effect of Targeted Education for Atrial Fibrillation Patients (Application Substudy)
NCT02581644Assessment of Effectiveness of Belatacept Patient Alert Card in Patients Following Renal Transplantation in a Sample of EU Countries
NCT02265744Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus
NCT00972244Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients
NCT00593944Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)
NCT04278144A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors
NCT04730544Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC.
NCT00388557Effect of Ketoconazole on the Pharmacokinetics of Vinflunine
NCT00926757Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B
NCT05621148REfractorinesS to Ibrutinib BTKi and Systemic Targeted Therapy
NCT00235248Aortic Arch Related Cerebral Hazard Trial (ARCH)
NCT03431948Stereotactic Body Radiotherapy (SBRT) Plus Immunotherapy for Cancer